We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 396

Medical devices: recent developments in the UK and the US
  • Baker Botts LLP
  • United Kingdom, USA
  • July 21 2014

Whether a company develops physical tools for medical purposes or has pre-existing pharmaceuticals that can be commercialised in new ways via


IP challenges for the personalised medicines industry - gene claims (part 1)
  • Barker Brettell LLP
  • European Union, United Kingdom, USA
  • May 9 2013

When you go to the doctor you expect to be asked a lot of questions about your symptoms and your lifestyle, as the doctor builds up a clinical


U.K. jumps on “pay-to-delay” bandwagon
  • Fish & Richardson PC
  • United Kingdom, USA
  • April 24 2013

The U.K. Office of Fair Trading ("OFT") jumped on the "pay-to-delay" bandwagon last week when it issued a "Statement of Objections," indicating a


UK Supreme Court steps into line with Europe, but rejects U.S. approach
  • McDermott Will & Emery
  • European Union, United Kingdom, USA
  • November 30 2011

The UK’s highest court recently considered the provisions of the European Patent Convention (EPC) centering on the “susceptible of industrial application” requirement in the context of a patent describing a DNA sequence for a new protein, Neutrokine-α, which was a member of a group of similar proteins known as the TNF ligand superfamily


Patrick Gunning
  • King & Wood Mallesons

Jason Markwell
  • Norton Rose Fulbright LLP

Suzanne L Rab
  • King & Spalding LLP

Mark A. Fischer
  • Duane Morris LLP

Anthony V. Lupo
  • Arent Fox LLP

Maura McIntosh
  • Herbert Smith Freehills LLP